Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-8,964
Closed -$2.5M 64
2025
Q2
$2.5M Sell
8,964
-690
-7% -$195K 0.55% 61
2025
Q1
$3.01M Sell
9,654
-9,089
-48% -$2.68M 0.55% 65
2024
Q4
$4.89M Buy
18,743
+11,010
+142% +$3.27M 0.89% 54
2024
Q3
$2.49M Sell
7,733
-9,029
-54% -$2.95M 0.46% 64
2024
Q2
$5.24M Sell
16,762
-119
-0.7% -$35K 0.73% 58
2024
Q1
$4.8M Sell
16,881
-3,399
-17% -$995K 0.7% 60
2023
Q4
$5.84M Sell
20,280
-9,435
-32% -$2.57M 0.89% 61
2023
Q3
$7.99M Sell
29,715
-16,077
-35% -$4.01M 1.31% 37
2023
Q2
$10.2M Sell
45,792
-83
-0.2% -$19.3K 1.74% 16
2023
Q1
$11.1M Buy
45,875
+21,126
+85% +$5.19M 2.03% 14
2022
Q4
$6.5M Sell
24,749
-8,212
-25% -$2.2M 1.22% 48
2022
Q3
$7.43M Sell
32,961
-481
-1% -$117K 1.51% 34
2022
Q2
$8.14M Sell
33,442
-13,900
-29% -$3.41M 1.61% 25
2022
Q1
$11.4M Sell
47,342
-238
-0.5% -$54.7K 1.97% 15
2021
Q4
$10.7M Buy
47,580
+357
+0.8% +$75.3K 1.73% 23
2021
Q3
$10M Buy
47,223
+21,709
+85% +$5M 1.71% 18
2021
Q2
$6.22M Sell
25,514
-87
-0.3% -$21.4K 1.22% 42
2021
Q1
$6.37M Sell
25,601
-1,696
-6% -$405K 1.37% 37
2020
Q4
$6.28M Buy
27,297
+1,298
+5% +$299K 1.37% 36
2020
Q3
$6.61M Buy
25,999
+2,552
+11% +$632K 1.64% 24
2020
Q2
$5.53M Buy
23,447
+8,732
+59% +$1.99M 1.5% 29
2020
Q1
$2.98M Buy
14,715
+590
+4% +$129K 0.93% 57
2019
Q4
$3.4M Sell
14,125
-15,941
-53% -$3.51M 0.88% 65
2019
Q3
$5.82M Sell
30,066
-3,424
-10% -$657K 0.89% 61
2019
Q2
$6.17M Hold
33,490
1% 57
2019
Q1
$6.36M Buy
33,490
+1,417
+4% +$271K 1.09% 55
2018
Q4
$6.24M Sell
32,073
-83
-0.3% -$16.2K 1.31% 48
2018
Q3
$6.67M Sell
32,156
-1,634
-5% -$322K 1.39% 37
2018
Q2
$6.25M Buy
33,790
+252
+0.8% +$44.6K 1.51% 33
2018
Q1
$7.45M Buy
33,538
+67
+0.2% +$12.3K 1.49% 38
2017
Q4
$5.82M Buy
+33,471
New +$5.92M 1.39% 38

Other funds holding AMGN

Bell Asset Management's AMGN Position: Q3 2025 in Review

Bell Asset Management sold out of Amgen (AMGN) in Q3 2025, closing a stake of 8,964 shares — an estimated $2.5M sold.

Bell Asset Management first reported a position in AMGN in Q4 2017 and held it in 31 quarters. The position peaked at $11.4M in Q1 2022. 2,819 funds tracked by Wall St. Rank hold AMGN as of Q3 2025.

  • Bell Asset Management reported no remaining Amgen position as of Q3 2025 after selling out during the quarter.
  • Bell Asset Management sold 8,964 Amgen shares in Q3 2025, an estimated $2.5M.
  • Bell Asset Management first reported a position in Amgen in Q4 2017 and held it in 31 quarters.
  • Bell Asset Management's Amgen position peaked at $11.4M in Q1 2022.
  • 2,819 funds tracked by Wall St. Rank held Amgen as of Q3 2025.

Based on Bell Asset Management's 13F filing for Q3 2025, filed 13 Nov 2025.